H H. Nechushtan

Jerusalem, JM 91120, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

De Novo Actionable Genomic Alterations in High-Grade Pulmonary Neuroendocrine Carcinomas: Therapeutic Implications of Targeted Treatment.

De Novo Actionable Genomic Alterations in High-Grade Pulmonary Neuroendocrine Carcinomas: Therapeutic Implications of Targeted Treatment.

Journal: Medical sciences (Basel, Switzerland)

Published: July 03, 2026

Phase II study of 1st-line durvalumab and platinum-etoposide in advanced large-cell neuroendocrine lung carcinoma (aLCNEC).

Phase II study of 1st-line durvalumab and platinum-etoposide in advanced large-cell neuroendocrine lung carcinoma (aLCNEC).

Journal: Cancer immunology, immunotherapy : CII

Published: January 27, 2026

Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.

Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.

Journal: Thoracic cancer

Published: April 23, 2025

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.

Journal: Journal for immunotherapy of cancer

Published: November 30, 2024

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events.

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events.

Journal: Journal for immunotherapy of cancer

Published: September 23, 2024

Tumor analysis of BRCA carriers reveals genomic similarities although separated by time.

Tumor analysis of BRCA carriers reveals genomic similarities although separated by time.

Journal: Discover oncology

Published: September 10, 2024

The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report.

The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report.

Journal: Anticancer research

Published: April 13, 2024

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer.

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer.

Journal: JCO precision oncology

Published: March 21, 2024

The functional role of Nudt2 in human triple negative breast cancer.

The functional role of Nudt2 in human triple negative breast cancer.

Journal: Frontiers in oncology

Published: January 02, 2024

Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy.

Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy.

Journal: Translational lung cancer research

Published: December 17, 2023

In Response.

In Response.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: August 28, 2023

Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations.

Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations.

Journal: Cancers

Published: August 23, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026